Home / Inspections / 1023507

FDA Inspection 1023507 — Oklahoma Blood Institute

Oklahoma Blood Institute — FEI 1626009

The FDA completed an inspection of Oklahoma Blood Institute on June 20, 2017 in Oklahoma City, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 20, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Oklahoma City, OK (United States)

Facility

Other inspections at this facility

  • 1231637 (NAI Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1093994 (VAI Fri Jun 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 945662 (VAI Thu Aug 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 876145 (NAI Wed May 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 810435 (NAI Thu Oct 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources